Valneva SE (VLA) Common Shares EUR0.15
Share news, reports & tips
18 October 2021 10:55
(Sharecast News) - A Covid-19 vaccine being developed by Valneva performed better than AstraZeneca's jab in trials, the French biotech announced on Monday, sending its shares soaring.
13 September 2021 09:43
(Sharecast News) - Shares of French pharmaceutical group Valneva tumbled on Monday after the UK government terminated a contract for the supply of at least 100m doses of its Covid-19 vaccine.
Company announcements Announcements
No company announcements about Valneva SE Common Shares EUR0.15 were found.
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2022. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.